Log In
BCIQ
Print this Print this
 

W805EC

  Manage Alerts
Collapse Summary General Information
Company NanoBio Corp.
DescriptionNanoemulsion-based vaccine adjuvant
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityAdjuvant
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsVaccine adjuvant against H5N1 pandemic influenza; Vaccine adjuvant against seasonal influenza virus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today